{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T22:26:26Z","timestamp":1791757586608,"version":"4.3.4"},"reference-count":227,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,2,23]],"date-time":"2024-02-23T00:00:00Z","timestamp":1708646400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82172688"],"award-info":[{"award-number":["82172688"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Bone is a common organ for solid tumor metastasis. Malignant bone tumor becomes insensitive to systemic therapy after colonization, followed by poor prognosis and high relapse rate. Immune and bone cells <jats:italic>in situ<\/jats:italic> constitute a unique immune microenvironment, which plays a crucial role in the context of bone metastasis. This review firstly focuses on lymphatic cells in bone metastatic cancer, including their function in tumor dissemination, invasion, growth and possible cytotoxicity-induced eradication. Subsequently, we examine myeloid cells, namely macrophages, myeloid-derived suppressor cells, dendritic cells, and megakaryocytes, evaluating their interaction with cytotoxic T lymphocytes and contribution to bone metastasis. As important components of skeletal tissue, osteoclasts and osteoblasts derived from bone marrow stromal cells, engaging in \u2018vicious cycle\u2019 accelerate osteolytic bone metastasis. We also explain the concept tumor dormancy and investigate underlying role of immune microenvironment on it. Additionally, a thorough review of emerging treatments for bone metastatic malignancy in clinical research, especially immunotherapy, is presented, indicating current challenges and opportunities in research and development of bone metastasis therapies.<\/jats:p>","DOI":"10.3389\/fimmu.2024.1335366","type":"journal-article","created":{"date-parts":[[2024,2,23]],"date-time":"2024-02-23T04:24:17Z","timestamp":1708662257000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":30,"title":["Multiple influence of immune cells in the bone metastatic cancer microenvironment on tumors"],"prefix":"10.3389","volume":"15","author":[{"given":"Shixin","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiangchu","family":"Lei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haochen","family":"Mou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenkan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingxiao","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Senxu","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eloy","family":"Yinwang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yucheng","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenxuan","family":"Shao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fangqian","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shenzhi","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xupeng","family":"Chai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zenan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiahao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zengjie","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaoming","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Binghao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,2,23]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1186\/s12885-017-3922-0","article-title":"Incidence of bone metastases in patients with solid tumors: analysis of oncology electronic medical records in the United States","volume":"18","author":"Hernandez","year":"2018","journal-title":"BMC Cancer"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1002\/jbmr.3618","article-title":"Understanding the bone in cancer metastasis","volume":"33","author":"Fornetti","year":"2018","journal-title":"J Bone Miner Res"},{"key":"B3","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1007\/BF00666208","article-title":"Osteolytic bone metastasis in breast cancer","volume":"32","author":"Yoneda","year":"1994","journal-title":"Breast Cancer Res Treat"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1038\/nrc1098","article-title":"The pathogenesis of cancer metastasis: the \u201cseed and soil\u201d hypothesis revisited","volume":"3","author":"Fidler","year":"2003","journal-title":"Nat Rev Cancer"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: the next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"key":"B6","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1186\/s13045-021-01103-4","article-title":"Spatial architecture of the immune microenvironment orchestrates tumor immunity and therapeutic response","volume":"14","author":"Fu","year":"2021","journal-title":"J Hematol Oncol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41423-019-0306-1","article-title":"Myeloid immunosuppression and immune checkpoints in the tumor microenvironment","volume":"17","author":"Nakamura","year":"2020","journal-title":"Cell Mol Immunol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1038\/nrendo.2010.227","article-title":"Bone metastasis: mechanisms and therapeutic opportunities","volume":"7","author":"Suva","year":"2011","journal-title":"Nat Rev Endocrinol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1007\/s10555-007-9109-4","article-title":"The bone microenvironment in metastasis; what is special about bone","volume":"27","author":"Bussard","year":"2008","journal-title":"Cancer Metastasis Rev"},{"key":"B10","doi-asserted-by":"publisher","first-page":"999","DOI":"10.3390\/ijms20040999","article-title":"The contribution of the immune system in bone metastasis pathogenesis","volume":"20","author":"Xiang","year":"2019","journal-title":"Int J Mol Sci"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1007\/s00109-013-1021-5","article-title":"The metastasis-promoting roles of tumor-associated immune cells","volume":"91","author":"Smith","year":"2013","journal-title":"J Mol Med (Berl)"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-019-0178-8","article-title":"Osteoimmunology: evolving concepts in bone-immune interactions in health and disease","volume":"19","author":"Tsukasaki","year":"2019","journal-title":"Nat Rev Immunol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1038\/onc.2009.416","article-title":"Immune infiltration in human tumors: a prognostic factor that should not be ignored","volume":"29","author":"Pag\u00e8s","year":"2010","journal-title":"Oncogene"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1016\/j.coi.2012.12.003","article-title":"T cell anergy, exhaustion, senescence, and stemness in the tumor microenvironment","volume":"25","author":"Crespo","year":"2013","journal-title":"Curr Opin Immunol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1097\/01.bor.0000231909.35043.da","article-title":"New insights into the role of T cells in the vicious cycle of bone metastases","volume":"18","author":"Fournier","year":"2006","journal-title":"Curr Opin Rheumatol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1002\/jbmr.4615","article-title":"Bone microenvironment-suppressed T cells increase osteoclast formation and osteolytic bone metastases in mice","volume":"37","author":"Arellano","year":"2022","journal-title":"J Bone Miner Res"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1172\/JCI157340","article-title":"The microbiome restrains melanoma bone growth by promoting intestinal NK and Th1 cell homing to bone","volume":"132","author":"Pal","year":"2022","journal-title":"J Clin Invest"},{"key":"B18","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1016\/j.cell.2019.10.029","article-title":"Differences in tumor microenvironment dictate T helper lineage polarization and response to immune checkpoint therapy","volume":"179","author":"Jiao","year":"2019","journal-title":"Cell"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202201451","article-title":"Genetically engineered hematopoietic stem cells deliver TGF-\u03b2 Inhibitor to enhance bone metastases immunotherapy","volume":"9","author":"Wang","year":"2022","journal-title":"Adv Sci (Weinh)"},{"key":"B20","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1038\/nri1806","article-title":"Regulatory T cells, tumour immunity and immunotherapy","volume":"6","author":"Zou","year":"2006","journal-title":"Nat Rev Immunol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1016\/j.semcancer.2005.11.006","article-title":"The impact of CD4+CD25+ Treg on tumor specific CD8+ T cell cytotoxicity and cancer","volume":"16","author":"Khazaie","year":"2006","journal-title":"Semin Cancer Biol"},{"key":"B22","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.molimm.2017.11.023","article-title":"Beyond the vicious cycle: The role of innate osteoimmunity, automimicry and tumor-inherent changes in dictating bone metastasis","volume":"110","author":"Owen","year":"2019","journal-title":"Mol Immunol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2404658","article-title":"Neighboring adipocytes participate in the bone marrow microenvironment of multiple myeloma cells","volume":"21","author":"Caers","year":"2007","journal-title":"Leukemia"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2010.03.007","article-title":"IFN-gamma-mediated upmodulation of MHC class I expression activates tumor-specific immune response in a mouse model of prostate cancer","volume":"28","author":"Martini","year":"2010","journal-title":"Vaccine"},{"key":"B25","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1046\/j.0019-2805.2001.01342.x","article-title":"Inhibition of B16 melanoma experimental metastasis by interferon-gamma through direct inhibition of cell proliferation and activation of antitumour host mechanisms","volume":"105","author":"Kakuta","year":"2002","journal-title":"Immunology"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1038\/s41417-022-00446-5","article-title":"Inhibition of myeloid PD-L1 suppresses osteoclastogenesis and cancer bone metastasis","volume":"29","author":"Zuo","year":"2022","journal-title":"Cancer Gene Ther"},{"key":"B27","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.3390\/cancers12041014","article-title":"Contribution of macrophages and T cells in skeletal metastasis","volume":"12","author":"Mendoza-Reinoso","year":"2020","journal-title":"Cancers (Basel)"},{"key":"B28","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1038\/nm730","article-title":"Tumor-associated B7-H1 promotes T-cell apoptosis: a potential mechanism of immune evasion","volume":"8","author":"Dong","year":"2002","journal-title":"Nat Med"},{"key":"B29","doi-asserted-by":"publisher","first-page":"2369","DOI":"10.1016\/j.immuni.2022.10.020","article-title":"The transcription factor IRF2 drives interferon-mediated CD8+ T cell exhaustion to restrict anti-tumor immunity","volume":"55","author":"Lukhele","year":"2022","journal-title":"Immunity"},{"key":"B30","doi-asserted-by":"publisher","first-page":"101165","DOI":"10.1016\/j.xcrm.2023.101165","article-title":"Osteoclast-derived apoptotic bodies inhibit naive CD8+ T cell activation via Siglec15, promoting breast cancer secondary metastasis","volume":"4","author":"Wu","year":"2023","journal-title":"Cell Rep Med"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-10-3922","article-title":"CD8+ T cells regulate bone tumor burden independent of osteoclast resorption","volume":"71","author":"Zhang","year":"2011","journal-title":"Cancer Res"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-19-3584","article-title":"ERR\u03b1 Expression in bone metastases leads to an exacerbated antitumor immune response","volume":"80","author":"Bouchet","year":"2020","journal-title":"Cancer Res"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1002\/jcp.24265","article-title":"Interleukin-27 expression modifies prostate cancer cell crosstalk with bone and immune cells in vitro","volume":"228","author":"Zolochevska","year":"2013","journal-title":"J Cell Physiol"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.165.11.6015","article-title":"Cutting edge: STAT6-deficient mice have enhanced tumor immunity to primary and metastatic mammary carcinoma","volume":"165","author":"Ostrand-Rosenberg","year":"2000","journal-title":"J Immunol"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-13-1364","article-title":"Targeting FSTL1 prevents tumor bone metastasis and consequent immune dysfunction","volume":"73","author":"Kudo-Saito","year":"2013","journal-title":"Cancer Res"},{"key":"B36","doi-asserted-by":"publisher","first-page":"a030338","DOI":"10.1101\/cshperspect.a030338","article-title":"T helper cell differentiation, heterogeneity, and plasticity","volume":"10","author":"Zhu","year":"2018","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0068171","article-title":"T cells induce pre-metastatic osteolytic disease and help bone metastases establishment in a mouse model of metastatic breast cancer","volume":"8","author":"Monteiro","year":"2013","journal-title":"PloS One"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.2174\/1574892812666170606123113","article-title":"Immune cells act as promising targets for the treatment of bone metastasis","volume":"12","author":"Luo","year":"2017","journal-title":"Recent Pat Anticancer Drug Discovery"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2002-04-1121","article-title":"Human myeloma cells stimulate the receptor activator of nuclear factor-kappa B ligand (RANKL) in T lymphocytes: a potential role in multiple myeloma bone disease","volume":"100","author":"Giuliani","year":"2002","journal-title":"Blood"},{"key":"B40","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/S0065-2776(07)96002-2","article-title":"Regulation of interferon-gamma during innate and adaptive immune responses","volume":"96","author":"Schoenborn","year":"2007","journal-title":"Adv Immunol"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.18632\/aging.v13i13","article-title":"Prognostic signatures associated with high infiltration of Tregs in bone metastatic prostate cancer","volume":"13","author":"Meng","year":"2021","journal-title":"Aging (Albany NY)"},{"key":"B42","doi-asserted-by":"publisher","first-page":"1578","DOI":"10.1038\/s41467-020-15429-z","article-title":"Differential regulation of breast cancer bone metastasis by PARP1 and PARP2","volume":"11","author":"Zuo","year":"2020","journal-title":"Nat Commun"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1038\/onc.2015.297","article-title":"Myeloid-specific TGF-\u03b2 signaling in bone promotes basic-FGF and breast cancer bone metastasis","volume":"35","author":"Meng","year":"2016","journal-title":"Oncogene"},{"key":"B44","doi-asserted-by":"publisher","first-page":"896","DOI":"10.4049\/jimmunol.177.2.896","article-title":"Suppression of antitumor immunity by IL-10 and TGF-beta-producing T cells infiltrating the growing tumor: influence of tumor environment on the induction of CD4+ and CD8+ regulatory T cells","volume":"177","author":"Jarnicki","year":"2006","journal-title":"J Immunol"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1038\/nature06306","article-title":"The inhibitory cytokine IL-35 contributes to regulatory T-cell function","volume":"450","author":"Collison","year":"2007","journal-title":"Nature"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1084\/jem.188.2.287","article-title":"CD4+CD25+ immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production","volume":"188","author":"Thornton","year":"1998","journal-title":"J Exp Med"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-04-1987","article-title":"Bone marrow is a reservoir for CD4+CD25+ regulatory T cells that traffic through CXCL12\/CXCR4 signals","volume":"64","author":"Zou","year":"2004","journal-title":"Cancer Res"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1038\/nature09707","article-title":"Tumour-infiltrating regulatory T cells stimulate mammary cancer metastasis through RANKL-RANK signalling","volume":"470","author":"Tan","year":"2011","journal-title":"Nature"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.4161\/onci.1.2.18480","article-title":"Regulatory T cells in the bone marrow microenvironment in patients with prostate cancer","volume":"1","author":"Zhao","year":"2012","journal-title":"Oncoimmunology"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-10-4246","article-title":"CD73-deficient mice have increased antitumor immunity and are resistant to experimental metastasis","volume":"71","author":"Stagg","year":"2011","journal-title":"Cancer Res"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1038\/nature14452","article-title":"Th17 cells transdifferentiate into regulatory T cells during resolution of inflammation","volume":"523","author":"Gagliani","year":"2015","journal-title":"Nature"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1093\/carcin\/bgt038","article-title":"Tumor necrosis factor receptor 2-dependent homeostasis of regulatory T cells as a player in TNF-induced experimental metastasis","volume":"34","author":"Chopra","year":"2013","journal-title":"Carcinogenesis"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1172\/JCI143764","article-title":"Exploiting bone niches: progression of disseminated tumor cells to metastasis","volume":"131","author":"Muscarella","year":"2021","journal-title":"J Clin Invest"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0046342","article-title":"Regulation of COX2 expression in mouse mammary tumor cells controls bone metastasis and PGE2-induction of regulatory T cell migration","volume":"7","author":"Karavitis","year":"2012","journal-title":"PloS One"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1126\/science.1198687","article-title":"Innate or adaptive immunity? The example of natural killer cells","volume":"331","author":"Vivier","year":"2011","journal-title":"Science"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1016\/j.molimm.2004.07.034","article-title":"Activation of NK cell cytotoxicity","volume":"42","author":"Smyth","year":"2005","journal-title":"Mol Immunol"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1038\/s41422-023-00810-6","article-title":"SCUBE2 mediates bone metastasis of luminal breast cancer by modulating immune-suppressive osteoblastic niches","volume":"33","author":"Wu","year":"2023","journal-title":"Cell Res"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1158\/1541-7786.MCR-08-0238","article-title":"Reciprocal effects of STAT5 and STAT3 in breast cancer","volume":"7","author":"Walker","year":"2009","journal-title":"Mol Cancer Res"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1172\/JCI44745","article-title":"The JAK2\/STAT3 signaling pathway is required for growth of CD44+CD24\u2013 stem cell-like breast cancer cells in human tumors","volume":"121","author":"Marotta","year":"2011","journal-title":"J Clin Invest"},{"key":"B60","doi-asserted-by":"publisher","first-page":"12258","DOI":"10.1038\/ncomms12258","article-title":"Decreased NK-cell tumour immunosurveillance consequent to JAK inhibition enhances metastasis in breast cancer models","volume":"7","author":"Bottos","year":"2016","journal-title":"Nat Commun"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V91.5.1706.1706_1706_1715","article-title":"Natural killer cell-mediated eradication of neuroblastoma metastases to bone marrow by targeted interleukin-2 therapy","volume":"91","author":"Lode","year":"1998","journal-title":"Blood"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1007\/s10555-007-9081-z","article-title":"Molecular pathogenesis and its therapeutic modalities of lung cancer metastasis to bone","volume":"26","author":"Sone","year":"2007","journal-title":"Cancer Metastasis Rev"},{"key":"B63","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.coi.2005.11.008","article-title":"The mononuclear phagocyte system","volume":"18","author":"Hume","year":"2006","journal-title":"Curr Opin Immunol"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1038\/nrc1256","article-title":"Tumour-educated macrophages promote tumour progression and metastasis","volume":"4","author":"Pollard","year":"2004","journal-title":"Nat Rev Cancer"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1038\/nature12034","article-title":"Macrophage biology in development, homeostasis and disease","volume":"496","author":"Wynn","year":"2013","journal-title":"Nature"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1038\/ni.1937","article-title":"Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigm","volume":"11","author":"Biswas","year":"2010","journal-title":"Nat Immunol"},{"key":"B67","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1186\/s13045-019-0760-3","article-title":"Tumor-associated macrophages in tumor metastasis: biological roles and clinical therapeutic applications","volume":"12","author":"Lin","year":"2019","journal-title":"J Hematol Oncol"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1038\/nri1733","article-title":"Monocyte and macrophage heterogeneity","volume":"5","author":"Gordon","year":"2005","journal-title":"Nat Rev Immunol"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1016\/S1471-4906(02)02302-5","article-title":"Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes","volume":"23","author":"Mantovani","year":"2002","journal-title":"Trends Immunol"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2014.01.006","article-title":"Transcriptome-based network analysis reveals a spectrum model of human macrophage activation","volume":"40","author":"Xue","year":"2014","journal-title":"Immunity"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2015.00263","article-title":"Much More than M1 and M2 Macrophages, There are also CD169(+) and TCR(+) Macrophages","volume":"6","author":"Ch\u00e1vez-Gal\u00e1n","year":"2015","journal-title":"Front Immunol"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.02035","article-title":"Human monocyte subsets and phenotypes in major chronic inflammatory diseases","volume":"10","author":"Kapellos","year":"2019","journal-title":"Front Immunol"},{"key":"B73","doi-asserted-by":"publisher","first-page":"14050","DOI":"10.1038\/s41598-019-50320-y","article-title":"mTORC1-mediated polarization of M1 macrophages and their accumulation in the liver correlate with immunopathology in fatal ehrlichiosis","volume":"9","author":"Haloul","year":"2019","journal-title":"Sci Rep"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.643771","article-title":"Macrophage biology and mechanisms of immune suppression in breast cancer","volume":"12","author":"Mehta","year":"2021","journal-title":"Front Immunol"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1172\/JCI80006","article-title":"Tumor-induced myeloid deviation: when myeloid-derived suppressor cells meet tumor-associated macrophages","volume":"125","author":"Ugel","year":"2015","journal-title":"J Clin Invest"},{"key":"B76","doi-asserted-by":"publisher","first-page":"1464","DOI":"10.1016\/j.ccell.2021.09.005","article-title":"Human prostate cancer bone metastases have an actionable immunosuppressive microenvironment","volume":"39","author":"Kfoury","year":"2021","journal-title":"Cancer Cell"},{"key":"B77","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1186\/s12929-019-0568-z","article-title":"Tumor-associated macrophages: an accomplice in solid tumor progression","volume":"26","author":"Chen","year":"2019","journal-title":"J BioMed Sci"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1002\/path.1027","article-title":"The role of tumour-associated macrophages in tumour progression: implications for new anticancer therapies","volume":"196","author":"Bingle","year":"2002","journal-title":"J Pathol"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1016\/S0896-8411(03)00045-3","article-title":"Interleukin-10 in the regulation of T cell-induced colitis","volume":"20","author":"Annacker","year":"2003","journal-title":"J Autoimmun"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccr.2005.10.012","article-title":"TGF-beta directly targets cytotoxic T cell functions during tumor evasion of immune surveillance","volume":"8","author":"Thomas","year":"2005","journal-title":"Cancer Cell"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2014.09.006","article-title":"Macrophage IL-10 blocks CD8+ T cell-dependent responses to chemotherapy by suppressing IL-12 expression in intratumoral dendritic cells","volume":"26","author":"Ruffell","year":"2014","journal-title":"Cancer Cell"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1101029","article-title":"Regulation of immune responses by prostaglandin E2","volume":"188","author":"Kalinski","year":"2012","journal-title":"J Immunol"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.1007\/s10059-013-0194-7","article-title":"Proangiogenic TIE2(+)\/CD31 (+) macrophages are the predominant population of tumor-associated macrophages infiltrating metastatic lymph nodes","volume":"36","author":"Kim","year":"2013","journal-title":"Mol Cells"},{"key":"B84","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/s13045-023-01442-4","article-title":"Myeloid-like tumor hybrid cells in bone marrow promote progression of prostate cancer bone metastasis","volume":"16","author":"Ye","year":"2023","journal-title":"J Hematol Oncol"},{"key":"B85","doi-asserted-by":"publisher","first-page":"R81","DOI":"10.1186\/bcr3195","article-title":"Bone marrow-derived, alternatively activated macrophages enhance solid tumor growth and lung metastasis of mammary carcinoma cells in a Balb\/C mouse orthotopic model","volume":"14","author":"Cho","year":"2012","journal-title":"Breast Cancer Res"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.1111\/j.1349-7006.2008.00880.x","article-title":"Inhibition of bone and muscle metastases of lung cancer cells by a decrease in the number of monocytes\/macrophages","volume":"99","author":"Hiraoka","year":"2008","journal-title":"Cancer Sci"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0073310","article-title":"Therapeutic effects of anti-CD115 monoclonal antibody in mouse cancer models through dual inhibition of tumor-associated macrophages and osteoclasts","volume":"8","author":"Fend","year":"2013","journal-title":"PloS One"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.1038\/onc.2012.166","article-title":"Macrophage cathepsin K promotes prostate tumor progression in bone","volume":"32","author":"Herroon","year":"2013","journal-title":"Oncogene"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.7150\/thno.29617","article-title":"CD137 promotes bone metastasis of breast cancer by enhancing the migration and osteoclast differentiation of monocytes\/macrophages","volume":"9","author":"Jiang","year":"2019","journal-title":"Theranostics"},{"key":"B90","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1038\/s41419-020-2435-y","article-title":"CCL5 derived from tumor-associated macrophages promotes prostate cancer stem cells and metastasis via activating \u03b2-catenin\/STAT3 signaling","volume":"11","author":"Huang","year":"2020","journal-title":"Cell Death Dis"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.1593\/neo.09988","article-title":"The chemokine CCL2 increases prostate tumor growth and bone metastasis through macrophage and osteoclast recruitment","volume":"11","author":"Mizutani","year":"2009","journal-title":"Neoplasia"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20191820","article-title":"Monocyte-derived macrophages promote breast cancer bone metastasis outgrowth","volume":"217","author":"Ma","year":"2020","journal-title":"J Exp Med"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.1172\/JCI92466","article-title":"Apoptosis-induced CXCL5 accelerates inflammation and growth of prostate tumor metastases in bone","volume":"128","author":"Roca","year":"2018","journal-title":"J Clin Invest"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.1007\/s10911-014-9320-1","article-title":"CSF-1R signaling in health and disease: a focus on the mammary gland","volume":"19","author":"Sullivan","year":"2014","journal-title":"J Mammary Gland Biol Neoplasia"},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.1016\/j.tips.2019.03.005","article-title":"Unexpected synergy reveals new therapeutic strategy in SCLC","volume":"40","author":"Drapkin","year":"2019","journal-title":"Trends Pharmacol Sci"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0157280","article-title":"Extratumoral heme oxygenase-1 (HO-1) expressing macrophages likely promote primary and metastatic prostate tumor growth","volume":"11","author":"Halin Bergstr\u00f6m","year":"2016","journal-title":"PloS One"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.1007\/s00018-021-03966-9","article-title":"Beyond immunosuppressive effects: dual roles of myeloid-derived suppressor cells in bone-related diseases","volume":"78","author":"Ling","year":"2021","journal-title":"Cell Mol Life Sci"},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.1038\/nri2506","article-title":"Myeloid-derived suppressor cells as regulators of the immune system","volume":"9","author":"Gabrilovich","year":"2009","journal-title":"Nat Rev Immunol"},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-13-0305","article-title":"Myeloid-derived suppressor cells as osteoclast progenitors: a novel target for controlling osteolytic bone metastasis","volume":"73","author":"Sawant","year":"2013","journal-title":"Cancer Res"},{"key":"B100","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0505168102","article-title":"An IL-7-dependent rebound in thymic T cell output contributes to the bone loss induced by estrogen deficiency","volume":"102","author":"Ryan","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B101","doi-asserted-by":"publisher","DOI":"10.1016\/j.imbio.2014.07.017","article-title":"Myeloid regulatory cells in tumor spreading and metastasis","volume":"220","author":"Keskinov","year":"2015","journal-title":"Immunobiology"},{"key":"B102","doi-asserted-by":"publisher","DOI":"10.1159\/000489184","article-title":"Molecular regulation of bone metastasis pathogenesis","volume":"46","author":"Wu","year":"2018","journal-title":"Cell Physiol Biochem"},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.3109\/00365521.2010.516450","article-title":"Up-regulated myeloid-derived suppressor cell contributes to hepatocellular carcinoma development by impairing dendritic cell function","volume":"46","author":"Hu","year":"2011","journal-title":"Scand J Gastroenterol"},{"key":"B104","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.182.1.240","article-title":"Cancer-expanded myeloid-derived suppressor cells induce anergy of NK cells through membrane-bound TGF-beta 1","volume":"182","author":"Li","year":"2009","journal-title":"J Immunol"},{"key":"B105","doi-asserted-by":"publisher","DOI":"10.1111\/sji.2010.72.issue-6","article-title":"Increased level of both CD4+FOXP3+ regulatory T cells and CD14+HLA-DR\u2013\/low myeloid-derived suppressor cells and decreased level of dendritic cells in patients with multiple myeloma","volume":"72","author":"Brimnes","year":"2010","journal-title":"Scand J Immunol"},{"key":"B106","doi-asserted-by":"publisher","first-page":"47","DOI":"10.15698\/cst","article-title":"Metabolic and functional reprogramming of myeloid-derived suppressor cells and their therapeutic control in glioblastoma","volume":"3","author":"Won","year":"2019","journal-title":"Cell Stress"},{"key":"B107","doi-asserted-by":"publisher","DOI":"10.20892\/j.issn.2095-3941.2015.0070","article-title":"Relationship of VEGF\/VEGFR with immune and cancer cells: staggering or forward","volume":"13","author":"Li","year":"2016","journal-title":"Cancer Biol Med"},{"key":"B108","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.ejca.2016.08.019","article-title":"The blockage of Notch signalling promoted the generation of polymorphonuclear myeloid-derived suppressor cells with lower immunosuppression","volume":"68","author":"Wang","year":"2016","journal-title":"Eur J Cancer"},{"key":"B109","doi-asserted-by":"publisher","DOI":"10.3892\/or","article-title":"Critical immunosuppressive effect of MDSC\u2212derived exosomes in the tumor microenvironment","volume":"45","author":"Rashid","year":"2021","journal-title":"Oncol Rep"},{"key":"B110","doi-asserted-by":"publisher","DOI":"10.4161\/onci.21990","article-title":"Myeloid-derived suppressor cells expand during breast cancer progression and promote tumor-induced bone destruction","volume":"1","author":"Danilin","year":"2012","journal-title":"Oncoimmunology"},{"key":"B111","doi-asserted-by":"publisher","DOI":"10.1016\/j.molimm.2019.11.014","article-title":"Chemokines and their receptors promoting the recruitment of myeloid-derived suppressor cells into the tumor","volume":"117","author":"Li","year":"2020","journal-title":"Mol Immunol"},{"key":"B112","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.00172","article-title":"MDSCs: key criminals of tumor pre-metastatic niche formation","volume":"10","author":"Wang","year":"2019","journal-title":"Front Immunol"},{"key":"B113","doi-asserted-by":"publisher","DOI":"10.1038\/nm.2830","article-title":"Silencing of Irf7 pathways in breast cancer cells promotes bone metastasis through immune escape","volume":"18","author":"Bidwell","year":"2012","journal-title":"Nat Med"},{"key":"B114","doi-asserted-by":"publisher","first-page":"2004659","DOI":"10.1080\/2162402X.2021.2004659","article-title":"Chronic stress promotes breast carcinoma metastasis by accumulating myeloid-derived suppressor cells through activating \u03b2-adrenergic signaling","volume":"10","author":"An","year":"2021","journal-title":"Oncoimmunology"},{"key":"B115","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-12-2202","article-title":"Myeloid-derived suppressor cells function as novel osteoclast progenitors enhancing bone loss in breast cancer","volume":"73","author":"Sawant","year":"2013","journal-title":"Cancer Res"},{"key":"B116","doi-asserted-by":"publisher","DOI":"10.1002\/med.20224","article-title":"Bone metastases: molecular mechanisms and novel therapeutic interventions","volume":"32","author":"Papachristou","year":"2012","journal-title":"Med Res Rev"},{"key":"B117","doi-asserted-by":"publisher","DOI":"10.1038\/32588","article-title":"Dendritic cells and the control of immunity","volume":"392","author":"Banchereau","year":"1998","journal-title":"Nature"},{"key":"B118","doi-asserted-by":"publisher","DOI":"10.1038\/nature06175","article-title":"Taking dendritic cells into medicine","volume":"449","author":"Steinman","year":"2007","journal-title":"Nature"},{"key":"B119","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1146\/annurev-immunol-100311-102839","article-title":"Decisions about dendritic cells: past, present, and future","volume":"30","author":"Steinman","year":"2012","journal-title":"Annu Rev Immunol"},{"key":"B120","doi-asserted-by":"publisher","DOI":"10.1084\/jem.137.5.1142","article-title":"Identification of a novel cell type in peripheral lymphoid organs of mice. I. Morphology, quantitation, tissue distribution","volume":"137","author":"Steinman","year":"1973","journal-title":"J Exp Med"},{"key":"B121","doi-asserted-by":"publisher","DOI":"10.1084\/jem.188.7.1359","article-title":"Immature dendritic cells phagocytose apoptotic cells via alphavbeta5 and CD36, and cross-present antigens to cytotoxic T lymphocytes","volume":"188","author":"Albert","year":"1998","journal-title":"J Exp Med"},{"key":"B122","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1146\/annurev.immunol.19.1.47","article-title":"Cross-presentation, dendritic cells, tolerance and immunity","volume":"19","author":"Heath","year":"2001","journal-title":"Annu Rev Immunol"},{"key":"B123","doi-asserted-by":"publisher","DOI":"10.1038\/nrc3258","article-title":"Cancer immunotherapy via dendritic cells","volume":"12","author":"Palucka","year":"2012","journal-title":"Nat Rev Cancer"},{"key":"B124","doi-asserted-by":"publisher","DOI":"10.1038\/ni1249","article-title":"Activation of bone marrow-resident memory T cells by circulating, antigen-bearing dendritic cells","volume":"6","author":"Cavanagh","year":"2005","journal-title":"Nat Immunol"},{"key":"B125","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1038\/bonekey.2014.95","article-title":"Immune regulation of bone metastasis","volume":"3","author":"Capietto","year":"2014","journal-title":"Bonekey Rep"},{"key":"B126","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2021-002856","article-title":"IL-6 contributes to metastatic switch via the differentiation of monocytic-dendritic progenitors into prometastatic immune cells","volume":"9","author":"Magidey-Klein","year":"2021","journal-title":"J Immunother Cancer"},{"key":"B127","doi-asserted-by":"publisher","DOI":"10.1007\/s12282-021-01270-9","article-title":"CD1a- and CD83-positive dendritic cells as prognostic markers of metastasis development in early breast cancer patients","volume":"28","author":"Giorello","year":"2021","journal-title":"Breast Cancer"},{"key":"B128","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1101855","article-title":"Depletion of plasmacytoid dendritic cells inhibits tumor growth and prevents bone metastasis of breast cancer cells","volume":"189","author":"Sawant","year":"2012","journal-title":"J Immunol"},{"key":"B129","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2022-005430","article-title":"TFAM deficiency in dendritic cells leads to mitochondrial dysfunction and enhanced antitumor immunity through cGAS-STING pathway","volume":"11","author":"Lu","year":"2023","journal-title":"J Immunother Cancer"},{"key":"B130","doi-asserted-by":"publisher","DOI":"10.1054\/bjoc.2001.2136","article-title":"A parathyroid-hormone-related-protein (PTH-rP)-specific cytotoxic T cell response induced by in vitro stimulation of tumour-infiltrating lymphocytes derived from prostate cancer metastases, with epitope peptide-loaded autologous dendritic cells and low-dose IL-2","volume":"85","author":"Correale","year":"2001","journal-title":"Br J Cancer"},{"key":"B131","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/1756-9966-31-3","article-title":"Inhibition of dendritic cell migration by transforming growth factor-\u03b21 increases tumor-draining lymph node metastasis","volume":"31","author":"Imai","year":"2012","journal-title":"J Exp Clin Cancer Res"},{"key":"B132","doi-asserted-by":"publisher","DOI":"10.1038\/36593","article-title":"A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function","volume":"390","author":"Anderson","year":"1997","journal-title":"Nature"},{"key":"B133","doi-asserted-by":"publisher","DOI":"10.1101\/gad.13.18.2412","article-title":"RANK is essential for osteoclast and lymph node development","volume":"13","author":"Dougall","year":"1999","journal-title":"Genes Dev"},{"key":"B134","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1084\/jem.191.3.495","article-title":"TRANCE, a tumor necrosis factor family member, enhances the longevity and adjuvant properties of dendritic cells in vivo","volume":"191","author":"Josien","year":"2000","journal-title":"J Exp Med"},{"key":"B135","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.0711823","article-title":"RANK-RANKL signaling pathway is critically involved in the function of CD4+CD25+ regulatory T cells in chronic colitis","volume":"182","author":"Totsuka","year":"2009","journal-title":"J Immunol"},{"key":"B136","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2015.1008334","article-title":"Cervical (pre)neoplastic microenvironment promotes the emergence of tolerogenic dendritic cells via RANKL secretion","volume":"4","author":"Demoulin","year":"2015","journal-title":"Oncoimmunology"},{"key":"B137","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-17-0606","article-title":"Co-administration of RANKL and CTLA4 antibodies enhances lymphocyte-mediated antitumor immunity in mice","volume":"23","author":"Ahern","year":"2017","journal-title":"Clin Cancer Res"},{"key":"B138","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2013.10.006","article-title":"Targeting tumor-stromal interactions in bone metastasis","volume":"141","author":"Esposito","year":"2014","journal-title":"Pharmacol Ther"},{"key":"B139","doi-asserted-by":"publisher","DOI":"10.1210\/endo.135.3.8070388","article-title":"Presence of messenger ribonucleic acid encoding osteocalcin, a marker of bone turnover, in bone marrow megakaryocytes and peripheral blood platelets","volume":"135","author":"Thiede","year":"1994","journal-title":"Endocrinology"},{"key":"B140","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V80.12.3112.bloodjournal80123112","article-title":"Characterization of human osteoblast and megakaryocyte-derived osteonectin (SPARC)","volume":"80","author":"Kelm","year":"1992","journal-title":"Blood"},{"key":"B141","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V79.4.936.bloodjournal794936","article-title":"Localization of platelet osteonectin at the internal face of the alpha-granule membranes in platelets and megakaryocytes","volume":"79","author":"Breton-Gorius","year":"1992","journal-title":"Blood"},{"key":"B142","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1002\/jbmr.5650070108","article-title":"Platelets contribute to circulating levels of bone sialoprotein in human","volume":"7","author":"Chenu","year":"1992","journal-title":"J Bone Miner Res"},{"key":"B143","doi-asserted-by":"publisher","DOI":"10.1016\/j.bone.2006.05.004","article-title":"Megakaryocyte-mediated inhibition of osteoclast development","volume":"39","author":"Kacena","year":"2006","journal-title":"Bone"},{"key":"B144","doi-asserted-by":"publisher","DOI":"10.1002\/jbmr.204","article-title":"Inhibitory effects of megakaryocytic cells in prostate cancer skeletal metastasis","volume":"26","author":"Li","year":"2011","journal-title":"J Bone Miner Res"},{"key":"B145","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2010.02.036","article-title":"Interaction between human-breast cancer metastasis and bone microenvironment through activated hepatocyte growth factor\/Met and beta-catenin\/Wnt pathways","volume":"46","author":"Previdi","year":"2010","journal-title":"Eur J Cancer"},{"key":"B146","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-16-1084","article-title":"Role of megakaryocytes in breast cancer metastasis to bone","volume":"77","author":"Jackson","year":"2017","journal-title":"Cancer Res"},{"key":"B147","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.abb.2014.08.009","article-title":"Reprint of: The Great Beauty of the osteoclast","volume":"561","author":"Cappariello","year":"2014","journal-title":"Arch Biochem Biophys"},{"key":"B148","doi-asserted-by":"publisher","DOI":"10.1038\/nature01658","article-title":"Osteoclast differentiation and activation","volume":"423","author":"Boyle","year":"2003","journal-title":"Nature"},{"key":"B149","doi-asserted-by":"publisher","DOI":"10.1007\/s11914-016-0315-2","article-title":"The bone microenvironment: a fertile soil for tumor growth","volume":"14","author":"Buenrostro","year":"2016","journal-title":"Curr Osteoporos Rep"},{"key":"B150","article-title":"Expression of interleukin 8 and not parathyroid hormone-related protein by human breast cancer cells correlates with bone metastasis in vivo","volume":"62","author":"Bendre","year":"2002","journal-title":"Cancer Res"},{"key":"B151","doi-asserted-by":"publisher","DOI":"10.1172\/JCI22123","article-title":"Platelet-derived lysophosphatidic acid supports the progression of osteolytic bone metastases in breast cancer","volume":"114","author":"Boucharaba","year":"2004","journal-title":"J Clin Invest"},{"key":"B152","doi-asserted-by":"publisher","DOI":"10.1172\/JCI118947","article-title":"Evidence for a causal role of parathyroid hormone-related protein in the pathogenesis of human breast cancer-mediated osteolysis","volume":"98","author":"Guise","year":"1996","journal-title":"J Clin Invest"},{"key":"B153","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajpath.2011.01.033","article-title":"CCN3 impairs osteoblast and stimulates osteoclast differentiation to favor breast cancer metastasis to bone","volume":"178","author":"Ouellet","year":"2011","journal-title":"Am J Pathol"},{"key":"B154","doi-asserted-by":"publisher","DOI":"10.1210\/en.140.10.4451","article-title":"Breast cancer cells interact with osteoblasts to support osteoclast formation","volume":"140","author":"Thomas","year":"1999","journal-title":"Endocrinology"},{"key":"B155","doi-asserted-by":"publisher","DOI":"10.1038\/nrc3055","article-title":"Cancer to bone: a fatal attraction","volume":"11","author":"Weilbaecher","year":"2011","journal-title":"Nat Rev Cancer"},{"key":"B156","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0702095104","article-title":"The macrophage-stimulating protein pathway promotes metastasis in a mouse model for breast cancer and predicts poor prognosis in humans","volume":"104","author":"Welm","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B157","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2014.00511","article-title":"Biology of the RANKL-RANK-OPG system in immunity, bone, and beyond","volume":"5","author":"Walsh","year":"2014","journal-title":"Front Immunol"},{"key":"B158","doi-asserted-by":"publisher","DOI":"10.1172\/JCI24918","article-title":"Osteoblast-derived PTHrP is a potent endogenous bone anabolic agent that modifies the therapeutic efficacy of administered PTH 1-34","volume":"115","author":"Miao","year":"2005","journal-title":"J Clin Invest"},{"key":"B159","doi-asserted-by":"publisher","DOI":"10.1002\/jev2.12068","article-title":"Small extracellular vesicles deliver osteolytic effectors and mediate cancer-induced osteolysis in bone metastatic niche","volume":"10","author":"Ma","year":"2021","journal-title":"J Extracell Vesicles"},{"key":"B160","doi-asserted-by":"publisher","DOI":"10.1007\/s11914-019-00545-7","article-title":"Monocyte chemoattractant protein-1 (MCP-1\/CCL2) drives activation of bone remodelling and skeletal metastasis","volume":"17","author":"Mulholland","year":"2019","journal-title":"Curr Osteoporos Rep"},{"key":"B161","doi-asserted-by":"publisher","first-page":"5196","DOI":"10.1038\/s41467-021-25473-y","article-title":"Exosomal miR-19a and IBSP cooperate to induce osteolytic bone metastasis of estrogen receptor-positive breast cancer","volume":"12","author":"Wu","year":"2021","journal-title":"Nat Commun"},{"key":"B162","doi-asserted-by":"publisher","DOI":"10.1172\/JCI144579","article-title":"RSPO2 and RANKL signal through LGR4 to regulate osteoclastic premetastatic niche formation and bone metastasis","volume":"132","author":"Yue","year":"2022","journal-title":"J Clin Invest"},{"key":"B163","doi-asserted-by":"publisher","first-page":"R149","DOI":"10.1186\/bcr3361","article-title":"ABCC5 supports osteoclast formation and promotes breast cancer metastasis to bone","volume":"14","author":"Mourskaia","year":"2012","journal-title":"Breast Cancer Res"},{"key":"B164","doi-asserted-by":"publisher","first-page":"116680","DOI":"10.1016\/j.bone.2023.116680","article-title":"Legumain inhibitor prevents breast cancer bone metastasis by attenuating osteoclast differentiation and function","volume":"169","author":"Chen","year":"2023","journal-title":"Bone"},{"key":"B165","doi-asserted-by":"publisher","DOI":"10.1038\/s41388-019-0873-8","article-title":"EGR1 regulates angiogenic and osteoclastogenic factors in prostate cancer and promotes metastasis","volume":"38","author":"Li","year":"2019","journal-title":"Oncogene"},{"key":"B166","doi-asserted-by":"publisher","DOI":"10.1172\/JCI157917","article-title":"IL-20RB mediates tumoral response to osteoclastic niches and promotes bone metastasis of lung cancer","volume":"132","author":"He","year":"2022","journal-title":"J Clin Invest"},{"key":"B167","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-15-1793","article-title":"Galectin-3 cleavage alters bone remodeling: different outcomes in breast and prostate cancer skeletal metastasis","volume":"76","author":"Nakajima","year":"2016","journal-title":"Cancer Res"},{"key":"B168","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-08-3358","article-title":"CD47 regulates bone mass and tumor metastasis to bone","volume":"69","author":"Ulu\u00e7kan","year":"2009","journal-title":"Cancer Res"},{"key":"B169","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s12943-017-0746-0","article-title":"microRNA-124 inhibits bone metastasis of breast cancer by repressing Interleukin-11","volume":"17","author":"Cai","year":"2018","journal-title":"Mol Cancer"},{"key":"B170","doi-asserted-by":"publisher","DOI":"10.1002\/jev2.12056","article-title":"Exosomes derived from osteogenic tumor activate osteoclast differentiation and concurrently inhibit osteogenesis by transferring COL1A1-targeting miRNA-92a-1-5p","volume":"10","author":"Yu","year":"2021","journal-title":"J Extracell Vesicles"},{"key":"B171","doi-asserted-by":"publisher","DOI":"10.1002\/jev2.12312","article-title":"Metastatic prostate cancer-derived extracellular vesicles facilitate osteoclastogenesis by transferring the CDCP1 protein","volume":"12","author":"Urabe","year":"2023","journal-title":"J Extracell Vesicles"},{"key":"B172","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202201974","article-title":"Large oncosome-loaded VAPA promotes bone-tropic metastasis of hepatocellular carcinoma via formation of osteoclastic pre-metastatic niche","volume":"9","author":"Zhang","year":"2022","journal-title":"Adv Sci (Weinh)"},{"key":"B173","doi-asserted-by":"publisher","first-page":"105662","DOI":"10.1016\/j.jmbbm.2023.105662","article-title":"Mechanoregulation may drive osteolysis during bone metastasis: A finite element analysis of the mechanical environment within bone tissue during bone metastasis and osteolytic resorption","volume":"138","author":"Verbruggen","year":"2023","journal-title":"J Mech Behav BioMed Mater"},{"key":"B174","doi-asserted-by":"publisher","DOI":"10.7150\/thno.62187","article-title":"CST6 protein and peptides inhibit breast cancer bone metastasis by suppressing CTSB activity and osteoclastogenesis","volume":"11","author":"Li","year":"2021","journal-title":"Theranostics"},{"key":"B175","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/s13046-023-02610-7","article-title":"Procoxacin bidirectionally inhibits osteoblastic and osteoclastic activity in bone and suppresses bone metastasis of prostate cancer","volume":"42","author":"Kong","year":"2023","journal-title":"J Exp Clin Cancer Res"},{"key":"B176","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc2214862","article-title":"Safety and efficacy of denosumab for fibrous dysplasia of bone","volume":"388","author":"de Castro","year":"2023","journal-title":"N Engl J Med"},{"key":"B177","doi-asserted-by":"publisher","DOI":"10.1007\/s10396-022-01201-x","article-title":"Ultrasound and microbubble-mediated drug delivery and immunotherapy","author":"Omata","year":"2001","journal-title":"J Med Ultrason"},{"key":"B178","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1002268","article-title":"Unconventional repertoire profile is imprinted during acute chikungunya infection for natural killer cells polarization toward cytotoxicity","volume":"7","author":"Petitdemange","year":"2011","journal-title":"PloS Pathog"},{"key":"B179","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2021-002591","article-title":"Mechanisms of regulatory T cell infiltration in tumors: implications for innovative immune precision therapies","volume":"9","author":"Nishikawa","year":"2021","journal-title":"J Immunother Cancer"},{"key":"B180","doi-asserted-by":"publisher","first-page":"4558","DOI":"10.1038\/s41467-021-24867-2","article-title":"STING suppresses bone cancer pain via immune and neuronal modulation","volume":"12","author":"Wang","year":"2021","journal-title":"Nat Commun"},{"key":"B181","doi-asserted-by":"publisher","DOI":"10.1126\/science.289.5484.1501","article-title":"The osteoblast: a sophisticated fibroblast under central surveillance","volume":"289","author":"Ducy","year":"2000","journal-title":"Science"},{"key":"B182","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/1476-4598-11-30","article-title":"Osteoblast-secreted collagen upregulates paracrine Sonic hedgehog signaling by prostate cancer cells and enhances osteoblast differentiation","volume":"11","author":"Zunich","year":"2012","journal-title":"Mol Cancer"},{"key":"B183","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.26024","article-title":"Steps in prostate cancer progression that lead to bone metastasis","volume":"128","author":"Jin","year":"2011","journal-title":"Int J Cancer"},{"key":"B184","doi-asserted-by":"publisher","DOI":"10.1002\/tox.23048","article-title":"Prostate cancer-secreted CCN3 uses the GSK3\u03b2 and \u03b2-catenin pathways to enhance osteogenic factor levels in osteoblasts","volume":"36","author":"Chen","year":"2021","journal-title":"Environ Toxicol"},{"key":"B185","doi-asserted-by":"publisher","first-page":"E992","DOI":"10.1073\/pnas.1718009115","article-title":"HIF signaling in osteoblast-lineage cells promotes systemic breast cancer growth and metastasis in mice","volume":"115","author":"Devignes","year":"2018","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B186","doi-asserted-by":"publisher","DOI":"10.1002\/jbmr.4313","article-title":"Osteoblasts generate testosterone from DHEA and activate androgen signaling in prostate cancer cells","volume":"36","author":"Moon","year":"2021","journal-title":"J Bone Miner Res"},{"key":"B187","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2017.02.003","article-title":"MAOA-dependent activation of shh-IL6-RANKL signaling network promotes prostate cancer metastasis by engaging tumor-stromal cell interactions","volume":"31","author":"Wu","year":"2017","journal-title":"Cancer Cell"},{"key":"B188","doi-asserted-by":"publisher","first-page":"1674","DOI":"10.3390\/ijms17101674","article-title":"Cancer cell colonisation in the bone microenvironment","volume":"17","author":"Kan","year":"2016","journal-title":"Int J Mol Sci"},{"key":"B189","doi-asserted-by":"publisher","DOI":"10.2174\/156652412802480871","article-title":"Plumbagin inhibits breast tumor bone metastasis and osteolysis by modulating the tumor-bone microenvironment","volume":"12","author":"Li","year":"2012","journal-title":"Curr Mol Med"},{"key":"B190","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2016.11.037","article-title":"Emerging biological principles of metastasis","volume":"168","author":"Lambert","year":"2017","journal-title":"Cell"},{"key":"B191","doi-asserted-by":"publisher","first-page":"130","DOI":"10.3390\/biom11020130","article-title":"Minimal residual disease, metastasis and immunity","volume":"11","author":"Badia-Ramentol","year":"2021","journal-title":"Biomolecules"},{"key":"B192","doi-asserted-by":"publisher","DOI":"10.1038\/s43018-020-0088-5","article-title":"The current paradigm and challenges ahead for the dormancy of disseminated tumor cells","volume":"1","author":"Risson","year":"2020","journal-title":"Nat Cancer"},{"key":"B193","doi-asserted-by":"publisher","DOI":"10.1172\/JCI43414","article-title":"Human prostate cancer metastases target the hematopoietic stem cell niche to establish footholds in mouse bone marrow","volume":"121","author":"Shiozawa","year":"2011","journal-title":"J Clin Invest"},{"key":"B194","doi-asserted-by":"publisher","DOI":"10.1038\/nrc3793","article-title":"Mechanisms of disseminated cancer cell dormancy: an awakening field","volume":"14","author":"Sosa","year":"2014","journal-title":"Nat Rev Cancer"},{"key":"B195","doi-asserted-by":"publisher","DOI":"10.1016\/j.stem.2014.02.002","article-title":"Metastatic stem cells: sources, niches, and vital pathways","volume":"14","author":"Oskarsson","year":"2014","journal-title":"Cell Stem Cell"},{"key":"B196","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1056\/NEJMoa050434","article-title":"A pooled analysis of bone marrow micrometastasis in breast cancer","volume":"353","author":"Braun","year":"2005","journal-title":"N Engl J Med"},{"key":"B197","article-title":"Early tumor cell dissemination in patients with clinically localized carcinoma of the prostate","volume":"3","author":"Melchior","year":"1997","journal-title":"Clin Cancer Res"},{"key":"B198","doi-asserted-by":"publisher","first-page":"340ra73","DOI":"10.1126\/scitranslmed.aad4059","article-title":"Dormant breast cancer micrometastases reside in specific bone marrow niches that regulate their transit to and from bone","volume":"8","author":"Price","year":"2016","journal-title":"Sci Transl Med"},{"key":"B199","doi-asserted-by":"publisher","DOI":"10.1359\/JBMR.041109","article-title":"Skeletal localization and neutralization of the SDF-1(CXCL12)\/CXCR4 axis blocks prostate cancer metastasis and growth in osseous sites in vivo","volume":"20","author":"Sun","year":"2005","journal-title":"J Bone Miner Res"},{"key":"B200","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0061873","article-title":"GAS6 receptor status is associated with dormancy and bone metastatic tumor formation","volume":"8","author":"Taichman","year":"2013","journal-title":"PloS One"},{"key":"B201","doi-asserted-by":"publisher","DOI":"10.1038\/nature10160","article-title":"In vivo imaging of Treg cells providing immune privilege to the haematopoietic stem-cell niche","volume":"474","author":"Fujisaki","year":"2011","journal-title":"Nature"},{"key":"B202","doi-asserted-by":"publisher","DOI":"10.1016\/j.critrevonc.2017.05.004","article-title":"Overcoming immunosuppression in bone metastases","volume":"117","author":"Reinstein","year":"2017","journal-title":"Crit Rev Oncol Hematol"},{"key":"B203","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2008-12-195792","article-title":"Tumor antigen-specific CD8 T cells infiltrating the tumor express high levels of PD-1 and are functionally impaired","volume":"114","author":"Ahmadzadeh","year":"2009","journal-title":"Blood"},{"key":"B204","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20100637","article-title":"Upregulation of Tim-3 and PD-1 expression is associated with tumor antigen-specific CD8+ T cell dysfunction in melanoma patients","volume":"207","author":"Fourcade","year":"2010","journal-title":"J Exp Med"},{"key":"B205","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2018.00086","article-title":"Anti-PD-1 and anti-CTLA-4 therapies in cancer: mechanisms of action, efficacy, and limitations","volume":"8","author":"Seidel","year":"2018","journal-title":"Front Oncol"},{"key":"B206","doi-asserted-by":"publisher","first-page":"215887","DOI":"10.1016\/j.canlet.2022.215887","article-title":"Immune checkpoints in osteosarcoma: Recent advances and therapeutic potential","volume":"547","author":"Wen","year":"2022","journal-title":"Cancer Lett"},{"key":"B207","doi-asserted-by":"publisher","DOI":"10.1093\/intimm\/8.5.765","article-title":"Expression of the PD-1 antigen on the surface of stimulated mouse T and B lymphocytes","volume":"8","author":"Agata","year":"1996","journal-title":"Int Immunol"},{"key":"B208","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/S0165-2478(02)00142-6","article-title":"Differential expression of PD-L1 and PD-L2, ligands for an inhibitory receptor PD-1, in the cells of lymphohematopoietic tissues","volume":"84","author":"Ishida","year":"2002","journal-title":"Immunol Lett"},{"key":"B209","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.00630","article-title":"PD-1 primarily targets TCR signal in the inhibition of functional T cell activation","volume":"10","author":"Mizuno","year":"2019","journal-title":"Front Immunol"},{"key":"B210","doi-asserted-by":"publisher","DOI":"10.1128\/MCB.25.21.9543-9553.2005","article-title":"CTLA-4 and PD-1 receptors inhibit T-cell activation by distinct mechanisms","volume":"25","author":"Parry","year":"2005","journal-title":"Mol Cell Biol"},{"key":"B211","doi-asserted-by":"publisher","first-page":"100505","DOI":"10.1016\/j.jbo.2023.100505","article-title":"Immune checkpoint inhibitors in bone metastasis: Clinical challenges, toxicities, and mechanisms","volume":"43","author":"Joseph","year":"2023","journal-title":"J Bone Oncol"},{"key":"B212","doi-asserted-by":"publisher","first-page":"2758","DOI":"10.3390\/biomedicines10112758","article-title":"Impact of bone metastases on patients with renal cell carcinoma or melanoma treated with combotherapy ipilimumab plus nivolumab","volume":"10","author":"Pham","year":"2022","journal-title":"Biomedicines"},{"key":"B213","doi-asserted-by":"publisher","DOI":"10.1007\/s11523-021-00832-3","article-title":"A multi-institutional, retrospective analysis of patients with metastatic renal cell carcinoma to bone treated with combination ipilimumab and nivolumab","volume":"16","author":"Desai","year":"2021","journal-title":"Target Oncol"},{"key":"B214","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1186\/s40425-019-0793-8","article-title":"Bone metastases and immunotherapy in patients with advanced non-small-cell lung cancer","volume":"7","author":"Landi","year":"2019","journal-title":"J Immunother Cancer"},{"key":"B215","doi-asserted-by":"publisher","DOI":"10.1016\/j.lungcan.2022.03.006","article-title":"Bone metastasis attenuates efficacy of immune checkpoint inhibitors and displays \u201ccold\u201d immune characteristics in Non-small cell lung cancer","volume":"166","author":"Zhu","year":"2022","journal-title":"Lung Cancer"},{"key":"B216","doi-asserted-by":"publisher","DOI":"10.1172\/JCI133334","article-title":"PD-1 blockade inhibits osteoclast formation and murine bone cancer pain","volume":"130","author":"Wang","year":"2020","journal-title":"J Clin Invest"},{"key":"B217","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2015.00605","article-title":"Natural killer cell-based therapies targeting cancer: possible strategies to gain and sustain anti-tumor activity","volume":"6","author":"Dahlberg","year":"2015","journal-title":"Front Immunol"},{"key":"B218","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1016\/j.crvi.2018.03.006","article-title":"Bacterial interspecies quorum sensing in the mammalian gut microbiota","volume":"341","author":"Xavier","year":"2018","journal-title":"C. R Biologies"},{"key":"B219","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1186\/s40425-017-0257-y","article-title":"Colony-stimulating factor 1 receptor (CSF1R) inhibitors in cancer therapy","volume":"5","author":"Cannarile","year":"2017","journal-title":"J Immunother Cancer"},{"key":"B220","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20141836","article-title":"CCL2-induced chemokine cascade promotes breast cancer metastasis by enhancing retention of metastasis-associated macrophages","volume":"212","author":"Kitamura","year":"2015","journal-title":"J Exp Med"},{"key":"B221","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1038\/nrclinonc.2016.217","article-title":"Tumour-associated macrophages as treatment targets in oncology","volume":"14","author":"Mantovani","year":"2017","journal-title":"Nat Rev Clin Oncol"},{"key":"B222","doi-asserted-by":"publisher","DOI":"10.2147\/OTT","article-title":"CXCR4 antagonism in combination with IDO1 inhibition weakens immune suppression and inhibits tumor growth in mouse breast cancer bone metastases","volume":"12","author":"Zhang","year":"2019","journal-title":"Onco Targets Ther"},{"key":"B223","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1016\/j.devcel.2019.10.026","article-title":"Dkk1 controls cell-cell interaction through regulation of non-nuclear \u03b2-catenin pools","volume":"51","author":"Johansson","year":"2019","journal-title":"Dev Cell"},{"key":"B224","doi-asserted-by":"publisher","DOI":"10.4161\/21624011.2014.954460","article-title":"Cancer chemotherapy agents target intratumoral dendritic cells to potentiate antitumor immunity","volume":"3","author":"M\u00fcller","year":"2014","journal-title":"Oncoimmunology"},{"key":"B225","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.03122","article-title":"Immunomodulatory protective effects of rb9 cyclic-peptide in a metastatic melanoma setting and the involvement of dendritic cells","volume":"10","author":"MaChado","year":"2019","journal-title":"Front Immunol"},{"key":"B226","doi-asserted-by":"publisher","DOI":"10.1158\/2326-6066.CIR-17-0341","article-title":"Interleukin-12 from CD103+ Batf3-dependent dendritic cells required for NK-cell suppression of metastasis","volume":"5","author":"Mittal","year":"2017","journal-title":"Cancer Immunol Res"},{"key":"B227","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2019-000474","article-title":"Vaccine efficacy against primary and metastatic cancer with in vitro-generated CD103+ conventional dendritic cells","volume":"8","author":"Zhou","year":"2020","journal-title":"J Immunother Cancer"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2024.1335366\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,23]],"date-time":"2024-02-23T04:24:25Z","timestamp":1708662265000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2024.1335366\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,23]]},"references-count":227,"alternative-id":["10.3389\/fimmu.2024.1335366"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2024.1335366","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,2,23]]},"article-number":"1335366"}}